$BWAY Cashflow Statement | Understand Stock

$BWAY

$11.32 -$0.31 (2.67%) Pre-market

$BWAY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Total comprehensive profit (loss)
Adjustments to reconcile net profit (loss) to net cash used in operating activities:
Depreciation and amortization
Depreciation of leased systems
Impairment and disposal of inventory and system components
Finance income, net
Cost of share-based payment
Income taxes
Total adjustments to reconcile loss
Changes in asset and liability items:
Increase in inventory
Decrease (increase) in trade receivables
Decrease (increase) in other current assets
Increase (decrease) in trade payables
Decrease (increase) in other financial assets
Increase in other accounts payable
Increase in deferred revenues
Total changes in asset and liability
Cash (paid) received during the year for:
Interest paid
Interest received
Income taxes paid
Total cash received during the year
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of property and equipment and system components, net
Proceeds from purchase of property and equipment and system components, net
Withdrawal of (investment in) short-term deposits, net
Purchase of financial assets measured at fair value
Withdrawal of restricted cash
Procceds from Deposits
Proceeds from lease assets
Proceeds from short-term bank deposits
Investment in short-term bank deposits
Investment in Commission asset
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from government grants
Repayment of liability in respect of research and development grants
Repayment of lease liabilities
Issuance of share capital, net
Exercise of share options
Issuance of warrants liability
Withdrawal of Investments in financial liability
Proceeds from issuance of shares, net
Net cash provided by (used in) financing activities
Exchange rate differences on balance of cash and cash equivalents

Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
(a) Significant non-cash transactions:
Termination of lease liability and right of-use
Right-of-use asset recognized with corresponding lease liability

Comments